Nuclear hormone receptors are transcription factors regulated by lipophilic hormones. They direct gene expression through association of co-activator or co-repressor complexes. The nuclear hormone receptor DAF-12 regulates C. elegans dauer diapause, developmental timing, stress resistance and lifespan. So far only a co-repressor,
din-1, and two genes involved in hormone biosynthesis,
daf-9/CYP450 and
daf-36/Rieske oxygenase, have been described suggesting that several more molecules, such as co-activators, remain to be identified.
daf-9 and
daf-36 mutants, as well as ligand binding mutants of
daf-12, share the same phenotypic profile, including constitutive dauer formation (Daf-c), migration defects in the gonad (Mig) and sensitivity to cholesterol deprivation. However, the
daf-36 null phenotype is much weaker than the
daf-9 null phenotype, suggesting a branched pathway. We have performed a genome-wide RNAi screen looking for enhancement of
daf-36 phenotypes. As expected, we found genes involved in hormone biosynthesis (e.g. a CYP450, a short chain dehydrogenase, a cytochrome P450 reductase) and transport (e.g. the Niemann-Pick C homolog
ncr-1). Another class of genes acts upstream of hormone synthesis and includes insulin signaling components (e.g.
akt-1). Interestingly, we identified several transcription factors or potential co-regulators (e.g. a nuclear hormone receptor,
lin-29/Zinc finger protein,
lin-42/period), as well as various chromatin factors. We are currently analyzing these genes for genetic interactions with each other and their epistatic relation to
daf-12. Finally, a number of mitochondrial genes enhanced the
daf-36 Daf-c phenotype suggesting an input of mitochondrial function into dauer formation. Further analysis should yield novel insights into nuclear hormone receptor signaling, as well as the physiological outputs on development and life span.